Form 4 for ADMA ADMA BIOLOGICS, INC.

Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001140361-26-004886 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-02-11	2026-02-09	ADMA	Guiheen Lawrence P.	Dir	A - Grant	$0.00	+10.7K	105.5K	+11%	$0
D	2026-02-11	2026-02-09	ADMA	Guiheen Lawrence P.	Dir	A - Grant	$0.00	+17.7K	17.7K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-09	A	A	10,690	$0.00	105,520	D	—	—	(F1) These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date. (F2) Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 89,385 shares of common stock owned by the Reporting Person.
2	Derivative	Stock Option (Right to Buy)	2026-02-09	A	A	17,730	$0.00	17,730	D	$16.37 · — to 2036-02-09	17,730 Common Stock	(F4) These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.